Relieving the Treatment Burden: Insights Into the Future of Anti-angiogenic Therapies for Neovascular AMD

Scroll to the Bottom of this Information to Begin this Course

---

 

Provided by Catalyst Medical Education, LLC and AKH Inc., Advancing Knowledge in Healthcare.

 

This activity is supported in part by an independent education grant from Allergan, Inc.

Credit Available

• Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for retina specialists and comprehensive ophthalmologists who treat diseases of the retina.

Program Overview

This symposium recording will review current challenges associated with frequent anti-vascular endothelial growth factor (VEGF) therapy, including the impact on patients, caregivers, and treating physicians. The impact of undertreatment on visual acuity will be discussed. Finally, new anti-VEGF and other anti-angiogenic compounds that are in development, including their pharmacologic properties, mode of action, latest safety and efficacy data, and promise of greater durability will be explored.

Learning Objectives

Upon completion of this activity, participants should be able to:

• Compare the safety and efficacy of the different anti-VEGF treatment regimens both in clinical trial and real-world settings
• Explain the multiple facets of treatment burden for neovascular age-related macular degeneration (AMD)
• Consider the medical needs and treatment burden for specific patients to individualize therapeutic strategies
• Review the pharmacologic properties and modes of action of anti-angiogenic compounds in late clinical development
• Review safety and efficacy data from clinical trials for anti-angiogenic therapies in development with special emphasis on phase 3 clinical programs

Faculty

Accreditation Statement

CME Credit provided by AKH Inc., Advancing Knowledge in Healthcare

 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

FACULTY

Dr. Do has disclosed the following relevant financial relationships:

• Consultant: Arie, Biotime, Genentech, Kodiak Sciences, Novartis, Regeneron, Santen

Dr. Kim has disclosed the following relevant financial relationships:

• Consultant: Allergan, Genentech, Kodiak, Novartis

Dr. Nguyen has disclosed the following relevant financial relationships:

• Advisory Boards: EyePoint, Genentech, Gliead, Regeneron, Santen

Dr. Steinle has disclosed no relevant financial relationships.

STAFF/REVIEWERS

Louis Settembrino, CHCP, Catalyst President and CEO: has disclosed no relevant financial relationships.

Dorothy Caputo, MA, BSN, RN, AKH Lead Nurse Planner/Reviewer: has disclosed no relevant financial relationships.

Patricia Brignoni, AKH Director of Operations/Reviewer: has disclosed no relevant financial relationships.

Method of Participation

There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:

1. Read the CME information and faculty disclosures.
2. Participate in the online activity.
3. Receive a passing score of 70% on the post test.
4. Submit the evaluation form.

Certificates will be emailed to the participant

 

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH, Inc., Advancing Knowledge in Healthcare specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

DISCLOSURE DECLARATION

It is the policy of AKH, Inc., Advancing Knowledge in Healthcare to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH, Inc., Advancing Knowledge in Healthcare prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content, notification of independent and certified CME expectations, referral to National Faculty Initiative training, restriction of topic area or content, restriction to discussion of science only, amendment of content to eliminate discussion of device or technique, use of other faculty for discussion of recommendations, independent review against criteria ensuring evidence support recommendation, moderator review, and peer review. AKH, Inc., www.relias.com Analytics | Assessments | Learning Advancing Knowledge in Healthcare planners and reviewers have no relevant financial relationships to disclose.

Contact Information

For CME questions, please contact: AKH at tbrignoni@akhcme.com.

---

---